Clinical trial
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin…
NCT00097513 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00097513 |
|---|---|
| Title | National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients |
| Official title | National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Subjects |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Dwarfism, Pituitary |
| Start date | Feb 1, 2003 |
| Completion | Jun 1, 2006 |
| First posted | Nov 25, 2004 |
| Last update posted | Nov 15, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: